Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Veralto's Growth Prospects Shine Despite Competitive Risks

In This Article:

Veralto Corporation VLTO is currently benefiting from its leadership in Water Quality and PQI segments, strategic acquisitions and growing dividends.

The companyrecently reported impressive fourth-quarter 2024 results, wherein earnings and revenues beat the Zacks Consensus Estimate. Quarterly EPS was 95 cents, which outpaced the Zacks Consensus Estimate by 8% and gained 9.2% on a year-over-year basis. Total revenues of $1.35 billion beat the consensus mark by a slight margin and increased 4.4% from the year-ago quarter.

How is VLTO Faring?

VLTO’s leadership in the Water Quality segment positions it to capitalize on robust growth opportunities in the United States. The industrial and municipal verticals serve as key drivers of this growth. In the industrial vertical, the CHIPS Act of 2022 provides a significant tailwind through semiconductor manufacturing grants, research investments and tax credits. Additionally, the global increase in semiconductor production enhances VLTO’s prospects, as ultra-pure water is critical for semiconductor manufacturing.

While the semiconductor industry has faced recent challenges, the long-term outlook remains favorable, driven by rising demand for digital tools, AI and autonomous technologies, which necessitate more semiconductor production. In the municipal vertical, increased U.S. government funding to address the country’s water infrastructure challenges offers a strong growth catalyst. This support is expected to boost investments in upgrading and modernizing water systems, further driving demand for VLTO’s solutions. The company’s WC revenues grew 3.4% year over year in 2024.

VLTO has established itself as a trusted leader in the Product Quality and Inspection (PQI) segment, serving the major consumer-packaged goods (CPG), life sciences, and pharmaceutical companies. The Marketing & Coding (M&C) sub-segment is the largest contributor to PQI’s revenues, reflecting its critical role in driving industry growth. M&C has become indispensable for CPG and pharmaceutical companies in a digital-first world. In the pharmaceutical sector, coding ensures regulatory compliance, facilitates accurate data management and enhances communication with healthcare professionals and patients.

These capabilities are vital as the industry increasingly relies on digital solutions for efficiency and transparency. For CPG companies, M&C integrates supply chain operations with consumer insights, enabling quick adaptation to market trends and fostering stronger customer engagement. This innovation helps businesses stay competitive in an ever-evolving landscape. By addressing these critical needs, VLTO empowers its clients to innovate, build stronger customer relationships and maintain a competitive edge. This robust positioning within high-growth industries highlights VLTO’s potential for sustained success, making it an appealing investment opportunity for stakeholders seeking exposure to innovative and resilient markets.